My credibility? I don't resort to multiple aliases
Post# of 30028
Since you claim to know so much about the street psychology, and have claimed this management team is clueless, why do you choose to remain invested, particularly with the dilution concerns you continue to post about? How about more posts about how the CEO should be replaced, or should have considered other funding options rather than dilution (for a pre-revenue company)? That will certainly add to your credibility, particularly when done using multiple aliases. I'm sure there are many firms who would be willing to provide funding to a pre-revenue biotech with some arrangement that doesn't involve shares as collateral.